$17.43 +0.09 (0.52%) Nektar Therapeutics - NASDAQ

Aug. 26, 2016 | 04:00 PM
Last Trade: 17.43
Trade Time: Aug 26 04:00 PM Eastern Daylight Time
Change: +0.09 (0.52%)
Prev Close: 17.34
Open: 17.32
Bid: 17.42
Ask: 17.43
  1. Weekly CEO Sells Highlight: Monolithic Power Systems, Five Prime Therapeutics, Nektar Therapeutics

    GuruFocus | Feb. 15, 2016 | 12:58PM EST
  2. Weekly CEO Sales Highlight: Monolithic Power Systems, Five Prime Therapeutics, Nektar Therapeutics

    GuruFocus | Feb. 14, 2016 | 14:30PM EST
  3. Benzinga's Top Initiations

    Benzinga | Jan. 28, 2016 | 09:53AM EST
  4. Nektar Announces First Patient Dosed in Phase 1/2 Clinical Study of NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine

    Benzinga | Dec. 8, 2015 | 09:00AM EST
  5. Baxalta Announces U.S. Availability of ADYNOVATE, New Treatment for Adult Patients With Hemophilia A With a Simple, Twice-Weekly Dosing Schedule

    Benzinga | Nov. 30, 2015 | 06:45AM EST
  6. Endologix, Express, Rockwell Automation Lead After-Hours Movers To Close Holiday Week

    Benzinga | Nov. 27, 2015 | 15:19PM EST
  7. Baxalta Announces FDA Approval of ADYNOVATE Treatment for Hemophilia A

    Benzinga | Nov. 14, 2015 | 08:08AM EST
  8. Nektar Submits Investigational New Drug Application (IND) for NKTR-214 To Treat Solid Tumor Malignancies

    Benzinga | Oct. 7, 2015 | 08:45AM EST
  9. Nektar Announces Receipt of $40 Million Milestone Payment Resulting from First Commercial Sale of MOVENTIG® (naloxegol) Tablets in Major European Market

    Benzinga | Sep. 1, 2015 | 08:31AM EST
  10. Baxalta's BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A

    Benzinga | Jul. 16, 2015 | 08:33AM EST
  11. Mid-Morning Market Update: Markets Open Lower; Lennar Beats Q2 Estimates

    Benzinga | Jun. 24, 2015 | 10:20AM EST
  12. 5 Healthcare Stocks With The Highest EPS Growth Forecast For Next 5 Years

    Benzinga | Feb. 20, 2015 | 09:36AM EST
  13. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  14. What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts

    Benzinga | Jan. 9, 2015 | 12:53PM EST
  15. 5 Healthcare Stocks With The Highest EPS Growth Forecast For Next 5 Years

    Benzinga | Jan. 9, 2015 | 09:19AM EST
Trading Center